Ever Supreme Bio Technology Co., Ltd (6712.TWO)

TWD 171.5

(-0.29%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 758.39 Million 627.51 Million 438.84 Million 70.59 Million 10.81 Million
Cost of Revenue 273.63 Million 212.95 Million 193.36 Million 88.54 Million 8.55 Million
Gross Profit 484.75 Million 414.55 Million 245.48 Million -17.94 Million 2.26 Million
Operating Expenses 147.02 Million 130.76 Million 129.27 Million 139.16 Million 137.75 Million
Selling, General and Administrative Expenses 47.91 Million 40.07 Million 45.13 Million 29.91 Million 43.24 Million
Research and Development Expenses 99.11 Million 90.69 Million 84.14 Million 109.24 Million 94.5 Million
Other Expenses - -29.05 Million 278.36 Million 16.84 Million -
Cost and Expenses 420.65 Million 343.71 Million 322.63 Million 227.7 Million 146.3 Million
Operating Income 337.73 Million 264.61 Million 397.43 Million -136.62 Million -135.48 Million
Interest Expense 201 Thousand 510 Thousand 618 Thousand 778 Thousand 582 Thousand
Income Tax Expense 83.61 Million 63.38 Million 27.22 Million -30.56 Million 25.4 Million
Earnings before Tax 623.01 Million 264.1 Million 396.82 Million -137.39 Million -119.62 Million
Net Income 539.39 Million 200.71 Million 369.6 Million -106.82 Million -94.21 Million
Earnings Per Share Basic 6.58 2.68 4.96 -1.58 -1.26
Earnings Per Share Diluted 6.56 2.66 4.91 -1.58 -1.26
Weighted Average Shares Outstanding 81.91 Million 74.9 Million 74.57 Million 67.8 Million 74.51 Million
Weighted Average Shares Outstanding (Diluted) 82.21 Million 75.37 Million 75.26 Million 67.8 Million 74.51 Million
Gross Margin 0.64 0.66 0.56 -0.25 0.21
EBIT Margin 0.86 0.48 0.99 -1.48 -11.41
Profit Margin 0.71 0.32 0.84 -1.51 -8.71
EBITDA 655.52 Million 300.16 Million 433.26 Million -104.69 Million -102.52 Million
Earnings Before Tax Margin 0.45 0.42 0.91 -1.94 -12.52

Income Statement Charts